Comparative Study of Physiological and Cerebrovascular Reactivity in Depression, at the Three Phases of Emotion

NCT ID: NCT02026622

Last Updated: 2025-12-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

76 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-02-28

Study Completion Date

2015-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective is to compare the physiological reactivity (heart and respiratory rates, galvanic skin response, cerebral perfusion, and startle) in the three phases of emotion between depressive subjects, subjects remitted from depression and control subjects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Major Depressive Disorder

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

major depressive disorder cerebrovascular reactivity emotional reactivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

3 groups of subjects

3 groups: depressive subjects, subjects remitted from depression and control subjects, with the same interventions.

psychometric tests, MRI, transcranial doppler and TPI, explicitative interview

Group Type OTHER

psychometric tests

Intervention Type BEHAVIORAL

NEO-PI, MADRS, MINI depression, MMSE, STAI-E, ERD, Anhedonia

MRI

Intervention Type DEVICE

ASL, rest f-MRI, FLAIR, white matter hyper intensities load

transcranial doppler and TPI

Intervention Type DEVICE

transcranial doppler TPI

explicitative interview

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

psychometric tests

NEO-PI, MADRS, MINI depression, MMSE, STAI-E, ERD, Anhedonia

Intervention Type BEHAVIORAL

MRI

ASL, rest f-MRI, FLAIR, white matter hyper intensities load

Intervention Type DEVICE

transcranial doppler and TPI

transcranial doppler TPI

Intervention Type DEVICE

explicitative interview

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Tissue Pulsatility Imaging

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female between 18 and 55
* Informed consent form signed
* Affiliated to a medical insurance
* visual and hearing abilities suitable for exams
* for the depressive group (group D): major depressive disorder according to the DSM-IV criteria as evaluated by the MINI test and MADRS score ≥22
* for the depressive patients in remission's group (group R) : matched on age, at least 1 history of major depressive disorder in the last 10 years and solved for more than 6 months, and MADRS score \< 9
* for the control subjects (group T) : matched on age, no psychiatric history, MADRS score \< 9

Exclusion Criteria

* psychotic disorder, bipolar disorder, addiction, suspected dementia (MMSE\<25)
* current betablockers or neuroleptics treatment
* any current organic unstable pathology
* history of serious cardiovascular disease (coronary syndrome, cardiac arrythmia, etc.)
* smoking \> 10 PY
* history of serious neurologic disease (stroke, cerebral tumour, serious cranial trauma, headache, ...)
* contra-indication to MRI
* uncorrected vision or audition troubles
* patient under juridic protection
* pregnancy, lactating or female without reliable contraception
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Tours

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital of Tours

Tours, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Siragusa MA, Rufin T, Courtois R, Belzung C, Andersson F, Brizard B, Dujardin PA, Cottier JP, Patat F, Remenieras JP, Gissot V, El-Hage W, Camus V, Desmidt T. Left amygdala volume and brain tissue pulsatility are associated with neuroticism: an MRI and ultrasound study. Brain Imaging Behav. 2021 Jun;15(3):1499-1507. doi: 10.1007/s11682-020-00348-w.

Reference Type RESULT
PMID: 32761564 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PHAO 2012 - TD / EMPHILINE

Identifier Type: -

Identifier Source: org_study_id